Literature DB >> 33766139

Inborn errors of immunity-recent advances in research on the pathogenesis.

Motoi Yamashita1, Kento Inoue1, Tsubasa Okano1, Tomohiro Morio2.   

Abstract

Primary immunodeficiency (PID) is a genetic disorder with a defect of one of the important components of our immune system. Classical PID has been recognized as a disorder with loss of function of the immune system. Recent studies have unveiled disorders with immune dysfunction with autoimmunity, autoinflammation, allergy, or predisposition to malignancy. Some of them were caused by an augmented immune function or a defect in immune regulation. With this background, the term inborn errors of immunity (IEI) is now used to refer to PID in the International Union of Immunological Societies (IUIS) classification. More than 400 responsible genes have been identified in patients with IEI so far, and importantly, many of them identified lately were caused by a heterologous mutation. Moreover, the onset is not necessarily in childhood, and we started seeing more and more IEI patients diagnosed in adulthood in the clinical settings. Recent advances in genetic analysis, including whole-exome analysis, whole-genome analysis, and RNA-seq have contributed to the identification of the disease-causing gene mutation. We also started to find heterogeneity of phenotype even in the patients with the same mutation in the same family, leading us to wonder if modifier gene or epigenetic modification is involved in the pathogenesis. In contrast, we accumulated many cases suggesting genetic heterogeneity is associated with phenotypic homogeneity. It has thus become difficult to deduce a responsible gene only from the phenotype in a certain type of IEI. Current curative therapy for IEI includes hematopoietic cell transplantation and gene therapy. Other curative therapeutic modalities have been long waited and are to be introduced in the future. These include a small molecule that inhibits the gain-of-function of the molecule- and genome-editing technology. Research on IEI will surely lead to a better understanding of other immune-related disorders including rheumatic diseases and atopic disorders.

Entities:  

Keywords:  Functional validation; Inborn errors of immunity; Next-generation sequencing

Year:  2021        PMID: 33766139      PMCID: PMC7992775          DOI: 10.1186/s41232-021-00159-6

Source DB:  PubMed          Journal:  Inflamm Regen        ISSN: 1880-8190


  42 in total

Review 1.  The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.

Authors:  R M Siegel; F K Chan; H J Chun; M J Lenardo
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.

Authors:  David Boutboul; Hye Sun Kuehn; Zoé Van de Wyngaert; Julie E Niemela; Isabelle Callebaut; Jennifer Stoddard; Christelle Lenoir; Vincent Barlogis; Catherine Farnarier; Frédéric Vely; Nao Yoshida; Seiji Kojima; Hirokazu Kanegane; Akihiro Hoshino; Fabian Hauck; Ludovic Lhermitte; Vahid Asnafi; Philip Roehrs; Shaoying Chen; James W Verbsky; Katherine R Calvo; Ammar Husami; Kejian Zhang; Joseph Roberts; David Amrol; John Sleaseman; Amy P Hsu; Steven M Holland; Rebecca Marsh; Alain Fischer; Thomas A Fleisher; Capucine Picard; Sylvain Latour; Sergio D Rosenzweig
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

3.  Normal hematologic parameters and fetal hemoglobin silencing with heterozygous IKZF1 mutations.

Authors:  Nour Abdulhay; Claudia Fiorini; Attila Kumánovics; Ashleigh A Sun; Jeannette Hansen-Rejali; Karl V Voelkerding; Sergio D Rosenzweig; Harry R Hill; Vijay G Sankaran
Journal:  Blood       Date:  2016-08-31       Impact factor: 22.113

Review 4.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

5.  APRIL-dependent lifelong plasmacyte maintenance and immunoglobulin production in humans.

Authors:  Tzu-Wen Yeh; Tsubasa Okano; Takuya Naruto; Motoi Yamashita; Miko Okamura; Kay Tanita; Likun Du; Qiang Pan-Hammarström; Noriko Mitsuiki; Satoshi Okada; Hirokazu Kanegane; Kohsuke Imai; Tomohiro Morio
Journal:  J Allergy Clin Immunol       Date:  2020-04-13       Impact factor: 10.793

6.  Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.

Authors:  Hye Sun Kuehn; Weiming Ouyang; Bernice Lo; Elissa K Deenick; Julie E Niemela; Danielle T Avery; Jean-Nicolas Schickel; Dat Q Tran; Jennifer Stoddard; Yu Zhang; David M Frucht; Bogdan Dumitriu; Phillip Scheinberg; Les R Folio; Cathleen A Frein; Susan Price; Christopher Koh; Theo Heller; Christine M Seroogy; Anna Huttenlocher; V Koneti Rao; Helen C Su; David Kleiner; Luigi D Notarangelo; Yajesh Rampertaap; Kenneth N Olivier; Joshua McElwee; Jason Hughes; Stefania Pittaluga; Joao B Oliveira; Eric Meffre; Thomas A Fleisher; Steven M Holland; Michael J Lenardo; Stuart G Tangye; Gulbu Uzel
Journal:  Science       Date:  2014-09-11       Impact factor: 47.728

7.  Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.

Authors:  Akihiro Hoshino; Satoshi Okada; Kenichi Yoshida; Naonori Nishida; Yusuke Okuno; Hiroo Ueno; Motoi Yamashita; Tsubasa Okano; Miyuki Tsumura; Shiho Nishimura; Sonoko Sakata; Masao Kobayashi; Haruna Nakamura; Junji Kamizono; Kanako Mitsui-Sekinaka; Takuya Ichimura; Shouichi Ohga; Yozo Nakazawa; Masatoshi Takagi; Kohsuke Imai; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Shigeaki Nonoyama; Tomohiro Morio; Hirokazu Kanegane
Journal:  J Allergy Clin Immunol       Date:  2016-12-06       Impact factor: 10.793

8.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

Review 9.  The Ikaros family of zinc-finger proteins.

Authors:  Yingzhi Fan; Duo Lu
Journal:  Acta Pharm Sin B       Date:  2016-06-24       Impact factor: 11.413

Review 10.  Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.

Authors:  Mathieu P Rodero; Yanick J Crow
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307

View more
  6 in total

Review 1.  Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.

Authors:  Paul Moss; Francis Berenbaum; Giuseppe Curigliano; Ayelet Grupper; Thomas Berg; Shanti Pather
Journal:  Vaccine       Date:  2022-05-27       Impact factor: 4.169

2.  Case Report: Analysis of Preserved Umbilical Cord Clarified X-Linked Anhidrotic Ectodermal Dysplasia With Immunodeficiency in Deceased, Undiagnosed Uncles.

Authors:  Satoshi Inaba; Yuta Aizawa; Yuki Miwa; Chihaya Imai; Hidenori Ohnishi; Hirokazu Kanegane; Akihiko Saitoh
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 3.  Endocrinopathies in Inborn Errors of Immunity.

Authors:  Kei Takasawa; Hirokazu Kanegane; Kenichi Kashimada; Tomohiro Morio
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

4.  Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions.

Authors:  Amir Hossein Saeidian; Leila Youssefian; Charles Y Huang; Fahimeh Palizban; Mahtab Naji; Zahra Saffarian; Hamidreza Mahmoudi; Azadeh Goodarzi; Soheila Sotoudeh; Fatemeh Vahidnezhad; Maliheh Amani; Narjes Tavakoli; Ali Ajami; Samaneh Mozafarpoor; Mehrdad Teimoorian; Saeed Dorgaleleh; Sima Shokri; Mohammad Shenagari; Nima Abedi; Sirous Zeinali; Paolo Fortina; Vivien Béziat; Emmanuelle Jouanguy; Jean-Laurent Casanova; Jouni Uitto; Hassan Vahidnezhad
Journal:  JCI Insight       Date:  2022-04-22

5.  Copy Number Analysis in a Large Cohort Suggestive of Inborn Errors of Immunity Indicates a Wide Spectrum of Relevant Chromosomal Losses and Gains.

Authors:  Maximilian Schieck; Rensheng Wan; Andrés Caballero-Oteyza; Winfried Hofmann; Alexis Virgil Cochino; Anna Shcherbina; Roya Sherkat; Clarisse Wache-Mainier; Anita Fernandez; Marc Sultan; Thomas Illig; Bodo Grimbacher; Michele Proietti; Doris Steinemann
Journal:  J Clin Immunol       Date:  2022-04-29       Impact factor: 8.542

6.  Targeted NGS Yields Plentiful Ultra-Rare Variants in Inborn Errors of Immunity Patients.

Authors:  Alice Grossi; Maurizio Miano; Marina Lanciotti; Francesca Fioredda; Daniela Guardo; Elena Palmisani; Paola Terranova; Giuseppe Santamaria; Francesco Caroli; Roberta Caorsi; Stefano Volpi; Marco Gattorno; Carlo Dufour; Isabella Ceccherini
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.